Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

15 high-cost drugs, including Ozempic, get major Medicare price reductions in latest negotiation round

A wave of vital prescription drugs is about to get a lot cheaper for people on Medicare. The Trump administration announced Tuesday that it has successfully negotiated lower prices for 15 drugs, including medications used for asthma, diabetes, arthritis, and multiple forms of cancer. The list includes Ozempic and Wegovy, Novo Nordisk’s drugs for Type 2 diabetes and weight management, as well as Rybelsus, the company’s oral GLP-1 for treating dia…

Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

The U.S. government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for patients in Medicare, the federal health insurance program for the elderly. Read more...

CMS negotiates a 70% discount for Ozempic and Wegovy

CMS has released the negotiated prices for the second set of drugs for Medicare Part D through the Inflation Reduction Act. Discounts range from 38% for Austedo and Austedo XR to 85% for Janumet and Janumet XR.